Kythera Biopharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Much of the innovation in cosmetic dermatology has come from the multibillion-dollar, largely unregulated cosmeceuticals industry. But Kythera Biopharmaceuticals aims to bring true, rigorous clinical science to the field, with prescription drugs that modulate novel biological pathways in aesthetic and restorative indications.